经既往放置的十二指肠支架行ERCP:多中心回顾性结局与不良事件研究
多中心回顾性研究纳入71例同时存在恶性胃出口梗阻和胆道梗阻、经既往放置的肠道支架行ERCP的患者。总体技术成功60/71(85%),I型40/46(87%)、II型16/21(76%)、III型4/4(100%);不良事件3例(3/71),为急性胆管炎2例和穿孔1例;术后平均生存时间4.6个月。作者认为该操作安全、技术及临床成功率高,但在II型梗阻中技术难度可能更大。
要点
- 总体技术成功率为60/71(85%),I型40/46(87%)、II型16/21(76%)、III型4/4(100%)。
- 不良事件3/71例:急性胆管炎2例、穿孔1例;术后平均生存时间4.6个月。
- 作者认为在II型梗阻中操作技术难度可能更大。
核心结论
- 经肠道支架行ERCP是安全的,技术和临床成功率高,但在II型梗阻情况下技术难度可能更大。
- 作者认为,在患者因恶性胃出口和胆道梗阻需经既往放置的肠道支架行ERCP这一特殊情况下,该操作可考虑作为一线选择。
研究设计与样本
- 多中心回顾性研究,纳入2家三级医疗中心共71例同时存在胃出口梗阻和胆道梗阻、经既往放置的肠道支架行ERCP的患者。
主要发现
- 总体技术成功60/71(85%);I型梗阻(胃出口梗阻位于乳头以上)技术成功40/46(87%),II型梗阻(胃出口梗阻位于乳头水平)16/21(76%),III型梗阻(胃出口梗阻位于乳头远端)4/4(100%)。
- 总体而言,获得技术成功的患者也获得了临床成功。
- 不良事件发生于3/71例患者:2例急性胆管炎和1例穿孔。
- 术后总体平均生存时间为4.6个月。
临床怎么用
- 作者认为,在患者因恶性胃出口和胆道梗阻需经既往放置的肠道支架行ERCP这一特殊情况下,该操作可考虑作为一线选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: ERCP performed through previously placed enteral stents is an uncommon procedure without a significant amount of supporting literature and with a wide reported range of technical success. The purpose of this study was to evaluate and better define the technical feasibility and safety of performing ERCP through enteral stents in patients with combined malignant biliary and gastric outlet obstruction. METHODS: We conducted a multicenter, retrospective study on 71 patients with combined gastric outlet and biliary obstruction who underwent ERCP through a previously placed enteral stent at 2 tertiary care centers. Outcomes included but were not limited to technical success, clinical success, need for repeat ERCP, adverse events, and survival time. RESULTS: Overall technical success was achieved in 60 of 71 patients (85%), with technical success of 40 of 46 (87%) in type I obstructions (gastric outlet obstruction above the ampulla), 16 of 21 (76%) in type II obstructions (gastric outlet obstruction at the level of the ampulla), and 4 of 4 (100%) in type III obstructions (gastric outlet obstruction distal to the ampulla). In general, patients who achieved technical success also achieved clinical success. Adverse events occurred in 3 patients (3/71): 2 patients with acute cholangitis and 1 patient with perforation. Average survival time after the procedure was 4.6 months overall. CONCLUSIONS: ERCP performed through enteral stents is safe, with a high technical and clinical success rate, but may be more technically challenging in the setting of type II obstructions. This procedure could be considered first line in the unique setting that a patient requires ERCP through a previously placed enteral stent for malignant gastric outlet and biliary obstruction.
引用
- Staub J, Siddiqui A, Taylor LJ, et al. ERCP performed through previously placed duodenal stents: a multicenter retrospective study of outcomes and adverse events. Gastrointest Endosc. 2018. PMID: 29425886. doi:10.1016/j.gie.2018.01.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。